WHO ICTRP trial
Multicenter prospective observational study of Antineoplastic cardiotoxicity and…
JPRN-UMIN000043889 · Japan Primary Registries Network (JPRN) · Not Recruiting
Key facts
| Trial ID | JPRN-UMIN000043889 |
|---|---|
| Public title | Multicenter prospective observational study of Antineoplastic cardiotoxicity and Chemotherapy-related Cardiac Dysfunction |
| Scientific title | Multicenter prospective observational study of Antineoplastic cardiotoxicity and Chemotherapy-related Cardiac Dysfunction - Multicenter prospective observational study of Antineoplastic cardiotoxicity and Chemotherapy-related Cardiac Dysfunction |
| Primary sponsor | Toranomon Hospital |
| Secondary sponsors | Kameda General Hospital St. Luke's International Hospital Juntendo University |
| Registry | Japan Primary Registries Network (JPRN) |
| Recruitment status | Not Recruiting |
| Study type | Observational |
| Phase | Not applicable |
| Countries | Japan |
| Conditions | Hematological tumors treated with CHOP therapy |
| Registration date | Dec 4, 2021 |
| Target size | 150 |
| Registry page | center6.umin.ac.jp |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: